1Clasen R, Schupp M, Foryst - Ludwig, et al. PPAR [ gamma ] - activating an - giotension type - 1 receptor blockers induce adiponectin. American Heart Association,Inc 2005 ;46( 1 ) :137 - 143.
2Mittra Y, Yamamoto N, Tsunekawa S, et al. Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes. Diabetes Care 2005 ;28:757 - 758.
3Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose - specific protein, adiponectin, in type 2 diabetic patients. Arte - rioscler Thromb Vasc Biol 2000 ;20:1595 - 1599.
2Lee M,Gardin JM,Lynch JC,et al.Diabetes mellitus and echocardiographic left ventricular function in frec-living elderly men and women:the Cardiovascular Health Study[J].Am Heart J,1997,133:36-43.
3Benson SC,Pershadsingh HA,Ho CL,et al.Identification of telmisartan as a unique angiotensin Ⅱ receptor antagonist with selective PPARgamma-modulating activity[J].Hypertension,2004,43(5):993-1002.
4Kurtz TW,Pravence M.Antidiabetic mechanisms of angiotensin-converting enzyme inbibitors and angiotensin Ⅱ receptor antagonists beyond the renin-angiotensin systen[J].Hypertension,2004,22(12):2253-2261.
5Bloorngarden ZT.Diabetes and hypertension[J].Diabetes Care,2001,24(9):1679-1684.
